Variant report
| Variant | esv15230 |
|---|---|
| Chromosome Location | chr12:123139888-123142070 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
(count:3 , 50 per page) page:
1
| No. | lncRNA name | Chromosome Location | lncRNA alias |
|---|---|---|---|
| 1 | lnc-KNTC1-3 | chr12:123141653-123141802 | NONHSAT031525 |
| 2 | lnc-KNTC1-3 | chr12:123140235-123140280 | l_749_chr12:123140234-123165633_testes |
| 3 | lnc-KNTC1-3 | chr12:123141072-123141805 | l_749_chr12:123140234-123165633_testes |
| No data |
| No data |
| No data |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs542075742 | chr12:123139923-123139924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs560544041 | chr12:123139930-123139931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs527866352 | chr12:123139942-123139943 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs539990252 | chr12:123139971-123139972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs377189458 | chr12:123139986-123139987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs113742173 | chr12:123140073-123140074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs75594663 | chr12:123140075-123140076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs554665711 | chr12:123140076-123140077 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs78866035 | chr12:123140079-123140080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs564985604 | chr12:123140148-123140149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs532192127 | chr12:123140202-123140203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs550598749 | chr12:123140289-123140290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs549575159 | chr12:123140330-123140331 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs568831887 | chr12:123140331-123140332 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs530033152 | chr12:123140358-123140359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs548474806 | chr12:123140367-123140368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs566577627 | chr12:123140369-123140370 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs184459287 | chr12:123140399-123140400 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs558825286 | chr12:123140405-123140406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs73224188 | chr12:123140411-123140412 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 21 | rs537899488 | chr12:123140415-123140416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs556146290 | chr12:123140455-123140456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs574455896 | chr12:123140498-123140499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs542146953 | chr12:123140513-123140514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs200240867 | chr12:123140541-123140542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs644989 | chr12:123140565-123140566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 27 | rs374974146 | chr12:123140566-123140567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs645348 | chr12:123140597-123140598 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 29 | rs190187002 | chr12:123140598-123140599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs577021825 | chr12:123140599-123140600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 31 | rs193241267 | chr12:123140639-123140640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs185583857 | chr12:123140642-123140643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs372819579 | chr12:123140670-123140671 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs553268655 | chr12:123140678-123140679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs529690839 | chr12:123140704-123140705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs548222103 | chr12:123140706-123140707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs560385604 | chr12:123140754-123140755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs386767114 | chr12:123140781-123140782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs77331130 | chr12:123140819-123140820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs552348710 | chr12:123140869-123140870 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs570510619 | chr12:123140894-123140895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs574775433 | chr12:123140985-123140986 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs537963253 | chr12:123141001-123141002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs141264360 | chr12:123141006-123141007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs568152606 | chr12:123141015-123141016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs376304073 | chr12:123141021-123141022 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs554218092 | chr12:123141070-123141071 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs1476292 | chr12:123141074-123141075 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
| 49 | rs150360996 | chr12:123141111-123141112 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
| 50 | rs539704795 | chr12:123141117-123141118 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Esophageal cancer | 21851588 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Testicular germ cell tumor | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Malaria | 21533027 | CNVD |
| Chronic lymphocytic leukemia | 22228453 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Chronic lymphocytic leukemia | 21670202 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Breast cancer | 21949216 | CNVD |
| Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Cancer | 21637783 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Glioblastoma multiforme | 19960244 | CNVD |
| Gastrointestinal stromal cancer | 20470368 | CNVD |
| Adenoid cystic carcinoma | 17372589 | CNVD |
| Lung cancer | 18438408 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Glioblastoma multiforme | 21390271 | CNVD |
| Cancer | 20164919 | CNVD |
| Cancer | 16751803 | CNVD |
| Biliary cancer | 20360734 | CNVD |
| Breast cancer | 20360734 | CNVD |
| Coronary artery disease | 20360734 | CNVD |
| Crohn''s disease | 20360734 | CNVD |
| Hypertension | 20360734 | CNVD |
| Rheumatoid arthritis | 20360734 | CNVD |
| Type 1 diabetes | 20360734 | CNVD |
| Type 2 diabetes | 20360734 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Ovarian cancer | 21720365 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Gastrointestinal stromal cancer | 20877625 | CNVD |
| T-cell prolymphocytic leukemia | 17713554 | CNVD |
| Schizophrenia | 18923514 | CNVD |
| Schizophrenia | 22241247 | CNVD |
| Cryptorchidism | 21048976 | CNVD |
| Myeloproliferative neoplasm | 20015882 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Medulloblastoma | 16783165 | CNVD |
| Breast cancer | 21806811 | CNVD |
| Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Beckwith-Wiedemann syndrome | 20648245 | CNVD |
| Developmental delay | 21457577 | CNVD |
| dysmorphic | 21457577 | CNVD |
| Ovine squamous-cell carcinoma | 17599052 | CNVD |
| Olfactory neuroblastoma | 18408657 | CNVD |
| Chordoma | 18071362 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr12:123120200-123140800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
| 2 | chr12:123128200-123147600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
| 3 | chr12:123135600-123141000 | Weak transcription | Primary monocytes fromperipheralblood | blood |
| 4 | chr12:123135800-123141000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 5 | chr12:123135800-123141200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
| 6 | chr12:123135800-123152800 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
| 7 | chr12:123136600-123140800 | Weak transcription | NHEK | skin |
| 8 | chr12:123136600-123154200 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
| 9 | chr12:123140800-123141400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
| 10 | chr12:123140800-123141600 | Enhancers | GM12878-XiMat | blood |
| 11 | chr12:123140800-123141600 | Enhancers | NHEK | skin |
| 12 | chr12:123140800-123153800 | Weak transcription | A549 | lung |
| 13 | chr12:123141000-123141400 | Enhancers | Primary monocytes fromperipheralblood | blood |
| 14 | chr12:123141000-123141600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 15 | chr12:123141200-123141600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
| 16 | chr12:123141400-123143800 | Weak transcription | Primary monocytes fromperipheralblood | blood |
| 17 | chr12:123141600-123142200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
| 18 | chr12:123141600-123143800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
| 19 | chr12:123141600-123144200 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |






